Tags

Type your tag names separated by a space and hit enter

Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season.
Euro Surveill. 2019 Nov; 24(45)ES

Abstract

We compared 2019 influenza seasonality and vaccine effectiveness (VE) in four southern hemisphere countries: Australia, Chile, New Zealand and South Africa. Influenza seasons differed in timing, duration, intensity and predominant circulating viruses. VE estimates were also heterogeneous, with all-ages point estimates ranging from 7-70% (I2: 33%) for A(H1N1)pdm09, 4-57% (I2: 49%) for A(H3N2) and 29-66% (I2: 0%) for B. Caution should be applied when attempting to use southern hemisphere data to predict the northern hemisphere influenza season.

Authors+Show Affiliations

World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, and Doherty Department, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.Influenza Division, Centers for Disease Control and Prevention, Atlanta, United States.National Influenza Centre, Institute of Environmental Science and Research, Wellington, New Zealand.Programa Nacional de Inmunizaciones, Ministerio de Salud, Santiago, Chile.Sección de Virus Respiratorios y Exantematicos, Instituto de Salud Publica de Chile, Santiago, Chile.Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.Department of Infectious Diseases, Alfred Health, and Central Clinical School, Monash University, Melbourne, Australia. School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.Discipline of General Practice, University of Adelaide, Adelaide, Australia.National Institute for Communicable Diseases, Johannesburg, South Africa.WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Reference and Research on Influenza, Melbourne, Australia.Pan American Health Organization(PAHO)/WHO Regional Office for the Americas, Washington, United States.Subdepartamento de Enfermedades Virales, Instituto de Salud Publica de Chile, Santiago, Chile.National Institute for Communicable Diseases, Johannesburg, South Africa.National Influenza Centre, Institute of Environmental Science and Research, Wellington, New Zealand.Programa Nacional de Inmunizaciones, Ministerio de Salud, Santiago, Chile.National Influenza Centre, Institute of Environmental Science and Research, Wellington, New Zealand.World Health Organization (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, and Doherty Department, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.Health Intelligence Team, Institute of Environmental Science and Research, Wellington, New Zealand.National Institute for Communicable Diseases, Johannesburg, South Africa.Health Intelligence Team, Institute of Environmental Science and Research, Wellington, New Zealand.Departamento de Epidemiologia, Ministerio de Salud, Santiago, Chile.WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Reference and Research on Influenza, Melbourne, Australia.Departamento de Epidemiologia, Ministerio de Salud, Santiago, Chile.MassGenics, Duluth, United States. Influenza Program, Centers for Disease Control and Prevention, Pretoria, South Africa. National Institute for Communicable Diseases, Johannesburg, South Africa. Influenza Division, Centers for Disease Control and Prevention, Atlanta, United States.Departamento de Epidemiologia, Ministerio de Salud, Santiago, Chile.National Institute for Communicable Diseases, Johannesburg, South Africa.National Institute for Communicable Diseases, Johannesburg, South Africa.Health Intelligence Team, Institute of Environmental Science and Research, Wellington, New Zealand.

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

31718744

Citation

Sullivan, Sheena G., et al. "Heterogeneity in Influenza Seasonality and Vaccine Effectiveness in Australia, Chile, New Zealand and South Africa: Early Estimates of the 2019 Influenza Season." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 24, no. 45, 2019.
Sullivan SG, Arriola CS, Bocacao J, et al. Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season. Euro Surveill. 2019;24(45).
Sullivan, S. G., Arriola, C. S., Bocacao, J., Burgos, P., Bustos, P., Carville, K. S., Cheng, A. C., Chilver, M. B., Cohen, C., Deng, Y. M., El Omeiri, N., Fasce, R. A., Hellferscee, O., Huang, Q. S., Gonzalez, C., Jelley, L., Leung, V. K., Lopez, L., McAnerney, J. M., ... Wood, T. (2019). Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 24(45). https://doi.org/10.2807/1560-7917.ES.2019.24.45.1900645
Sullivan SG, et al. Heterogeneity in Influenza Seasonality and Vaccine Effectiveness in Australia, Chile, New Zealand and South Africa: Early Estimates of the 2019 Influenza Season. Euro Surveill. 2019;24(45) PubMed PMID: 31718744.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season. AU - Sullivan,Sheena G, AU - Arriola,Carmen S, AU - Bocacao,Judy, AU - Burgos,Pamela, AU - Bustos,Patricia, AU - Carville,Kylie S, AU - Cheng,Allen C, AU - Chilver,Monique Bm, AU - Cohen,Cheryl, AU - Deng,Yi-Mo, AU - El Omeiri,Nathalie, AU - Fasce,Rodrigo A, AU - Hellferscee,Orienka, AU - Huang,Q Sue, AU - Gonzalez,Cecilia, AU - Jelley,Lauren, AU - Leung,Vivian Ky, AU - Lopez,Liza, AU - McAnerney,Johanna M, AU - McNeill,Andrea, AU - Olivares,Maria F, AU - Peck,Heidi, AU - Sotomayor,Viviana, AU - Tempia,Stefano, AU - Vergara,Natalia, AU - von Gottberg,Anne, AU - Walaza,Sibongile, AU - Wood,Timothy, PY - 2019/11/14/entrez PY - 2019/11/14/pubmed PY - 2020/8/11/medline KW - influenza KW - influenza vaccines KW - sentinel surveillance KW - southern hemisphere KW - vaccine effectiveness JF - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin JO - Euro Surveill VL - 24 IS - 45 N2 - We compared 2019 influenza seasonality and vaccine effectiveness (VE) in four southern hemisphere countries: Australia, Chile, New Zealand and South Africa. Influenza seasons differed in timing, duration, intensity and predominant circulating viruses. VE estimates were also heterogeneous, with all-ages point estimates ranging from 7-70% (I2: 33%) for A(H1N1)pdm09, 4-57% (I2: 49%) for A(H3N2) and 29-66% (I2: 0%) for B. Caution should be applied when attempting to use southern hemisphere data to predict the northern hemisphere influenza season. SN - 1560-7917 UR - https://www.unboundmedicine.com/medline/citation/31718744/Heterogeneity_in_influenza_seasonality_and_vaccine_effectiveness_in_Australia_Chile_New_Zealand_and_South_Africa:_early_estimates_of_the_2019_influenza_season_ L2 - http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2019.24.45.1900645 DB - PRIME DP - Unbound Medicine ER -